Martin Gleize - Roche Bobois Group Board
| RBO Stock | 37.00 0.50 1.37% |
Insider
Martin Gleize is Group Board of Roche Bobois
| Age | 46 |
| Phone | 33 1 53 46 10 00 |
| Web | https://www.roche-bobois.com |
Roche Bobois Management Efficiency
The company has return on total asset (ROA) of 0.0645 % which means that it generated a profit of $0.0645 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3583 %, meaning that it generated $0.3583 on every $100 dollars invested by stockholders. Roche Bobois' management efficiency ratios could be used to measure how well Roche Bobois manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Joao Salles | Verallia | 38 | |
| Aurelin Poncin | SA Catana Group | N/A | |
| Carole Alexandre | Maisons du Monde | N/A | |
| Regis Massuyeau | Maisons du Monde | N/A | |
| Lionel Monroe | Thermador Groupe SA | 56 | |
| Claudia Scarico | Verallia | 32 | |
| Cecile Marsac | Verallia | 56 | |
| Yohann Catherine | Maisons du Monde | N/A | |
| Robert Seminara | Verallia | 47 | |
| Sebastien Moynot | Verallia | 47 | |
| Sandrine Perrier | Vetoquinol | N/A | |
| Mathilde Joannard | Verallia | N/A | |
| MarieJose Donsion | Verallia | 45 | |
| Alexandra Boucheron | Verallia | N/A | |
| Philippe Bernardet | Thermador Groupe SA | 65 | |
| Hugues Denissel | Verallia | N/A | |
| Fabienne Bochet | Thermador Groupe SA | 49 | |
| Sylvain Artigau | Verallia | 47 | |
| Laurent Thore | Vetoquinol | N/A | |
| Agathe Lacoste | Maisons du Monde | N/A | |
| Catherine Filoche | Maisons du Monde | N/A | |
Management Performance
| Return On Equity | 0.36 | |||
| Return On Asset | 0.0645 |
Roche Bobois Leadership Team
Elected by the shareholders, the Roche Bobois' board of directors comprises two types of representatives: Roche Bobois inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Roche. The board's role is to monitor Roche Bobois' management team and ensure that shareholders' interests are well served. Roche Bobois' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Roche Bobois' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Martin Gleize, Group Board | ||
| Guillaume Demulier, Chairman Board | ||
| Sasha Brinkley, Sales Director | ||
| Antonin Roche, Member Board | ||
| Lucie HenmanRoche, Censeur Board | ||
| Eric Amourdedieu, MD CEO | ||
| Stephanie Berson, Group Officer |
Roche Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Roche Bobois a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.36 | |||
| Return On Asset | 0.0645 | |||
| Profit Margin | 0.08 % | |||
| Operating Margin | 0.11 % | |||
| Current Valuation | 421.26 M | |||
| Shares Outstanding | 9.9 M | |||
| Shares Owned By Insiders | 88.50 % | |||
| Shares Owned By Institutions | 0.57 % | |||
| Price To Book | 3.60 X | |||
| Price To Sales | 0.92 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Roche Stock
Roche Bobois financial ratios help investors to determine whether Roche Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Roche with respect to the benefits of owning Roche Bobois security.